Not Medicare Enrolled

Dr. Lori Grabois, M.D.

Name: Federal CMS public records for Dr. Lori Grabois (NPI 1952380933)
Creator: U.S. Centers for Medicare & Medicaid Services
License: https://www.usa.gov/government-works

Psychiatry · Aventura, FL

Low-engagement

21110 BISCAYNE BLVD, Aventura, FL 33180

3059325500

In practice since 2006 (20 years)

NPI: 1952380933 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 2 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Grabois from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Grabois? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Grabois

Dr. Lori Grabois is a psychiatry in Aventura, FL, with 20 years in practice.

Between the years covered by Open Payments, Dr. Grabois received a total of $12,627 from 32 pharmaceutical and/or device companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Grabois is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $12,627 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$12,627

Total received (2018-2024)

Avg $1,804/year across 7 years

Top 7% in FL for psychiatry

Companies

582

Individual payments

All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel

Food, beverages, travel, and lodging — typically low-value

$12,627 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$1,714

2023

$2,095

2022

$2,600

2021

$2,185

2020

$1,221

2019

$1,239

2018

$1,573

Payments by company (2024)

Consulting

Speaking

Meals & Travel

Research

Lundbeck LLC

$1,422

Otsuka America Pharmaceutical, Inc.

$1,193

Vanda Pharmaceuticals Inc.

$1,031

ITI, Inc.

$1,010

Janssen Pharmaceuticals, Inc

$928

Teva Pharmaceuticals USA, Inc.

$834

Takeda Pharmaceuticals U.S.A., Inc.

$650

Allergan Inc.

$541

Axsome Therapeutics, Inc.

$534

Bausch Health US, LLC

$533

ABBVIE INC.

$454

Avanir Pharmaceuticals, Inc.

$393

Neurocrine Biosciences, Inc.

$389

AbbVie Inc.

$361

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)

$352

Allergan, Inc.

$350

Alkermes, Inc.

$300

Sunovion Pharmaceuticals Inc.

$289

Shire North American Group Inc

$227

Almatica Pharma LLC

$204

E.R. Squibb & Sons, L.L.C.

$119

Tris Pharma Inc

$118

Adlon Therapeutics L.P.

$78

IDORSIA PHARMACEUTICALS US INC

$69

DySIS Medical, Inc.

$55

Ironshore Pharmaceuticals Inc.

$39

Supernus Pharmaceuticals, Inc.

$36

Alfasigma USA, Inc.

$33

Noven Therapeutics, LLC

$24

LivaNova USA, Inc.

$21

Corium, LLC

$20

Eisai Inc.

$19

Top 3 companies account for 28.9% of total payments

Associated products mentioned in payments ›

ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Austedo XR · Auvelity · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · Dyanavel XR · FANAPT · Fanapt · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · MYDAYIS · NUEDEXTA · ONGENTYS · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · TRINTELLIX · Trintellix · Ultra 2.0 · VIIBRYD · VNS - Symmetry · VRAYLAR · VYVANSE · WELLBUTRIN · Xelstrym

Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for psychiatry in FL.

Looking for a psychiatry in Aventura?
Compare psychiatrys in the Aventura area by procedure volume, costs, and industry payment transparency.

Browse psychiatrys nearby

Geographic Context

Psychiatrys within 10 mi

618

Per 100K population

23.0

County median income

$68,694

Nearest hospital

HCA FLORIDA AVENTURA HOSPITAL
0.0 mi

Data Sources

Provider Registry	✓ NPPES	Weekly updates
Medicare Enrollment	— Not enrolled	N/A
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not public	N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Grabois is a psychiatry, and high industry engagement (low-engagement, top 7%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Grabois receive payments from pharmaceutical companies?

Yes. Dr. Grabois received a total of $12,627 from 32 companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Grabois) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city

Psychiatrys in Aventura

Browse psychiatrys in Aventura ranked by procedure volume and transparency data.

Highest volume

Top Psychiatrys in FL

Psychiatrys ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Psychiatrys in FL

Which FL psychiatrys receive the most from drug and device companies.

By company

Lundbeck LLC Payments to Doctors

See all physicians who received payments from Lundbeck LLC.

By company

Otsuka America Pharmaceutical, Inc. Payments to Doctors

See all physicians who received payments from Otsuka America Pharmaceutical, Inc..

By company

Vanda Pharmaceuticals Inc. Payments to Doctors

See all physicians who received payments from Vanda Pharmaceuticals Inc..

About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology